Patent application number | Description | Published |
20090054856 | REDUCED-PRESSURE SYSTEM AND METHOD EMPLOYING A GASKET - A reduced-pressure treatment system for treating a tissue site on a patient includes a gasket releasably attached around a perimeter of the tissue site that may remain in place for an extended time and allows an over-drape to be attached to it. The system and method further may include a manifold sized and configured to be placed in contact with the tissue site; the over-drape positioned over the manifold and sealed to the gasket to create a sealed space between the over-drape and the tissue site; and a reduced-pressure source fluidly coupled to the sealed space to deliver reduced pressure to the tissue site. A method is also presented. | 02-26-2009 |
20100069829 | THERAPY DELIVERY SYSTEMS AND METHODS - Fluid removal systems and methods for removing fluid from a tissue site are presented. The system includes a semi-permeable inbound conduit, which is fluidly coupled to a treatment-fluid delivery unit, for placement proximate to a tissue site, and a semi-permeable outbound conduit, which is fluidly coupled to the inbound conduit and to a treatment-fluid collector, for placement proximate to the tissue site on the patient. The treatment-fluid collector receives the treatment fluid and a recruited fluid from the tissue site. A recruited-fluid determination unit may be coupled to the treatment-fluid collector to determine a volume of fluid recruited from the patient. The treatment fluid is any fluid (including a gas) that pulls fluid from the interstitial and intracellular space. A reduced-pressure treatment subsystem may also be included, among other things, for removing ascites and other fluids from a body cavity. | 03-18-2010 |
20100069885 | SYSTEMS AND METHODS FOR CONTROLLING INFLAMMATORY RESPONSE - A method and system for controlling inflammatory response at an internal tissue site of a patient utilizes a reduced-pressure treatment device. Controlling the inflammatory response may be accomplished in a number of ways that involve treating the inflammatory milieu. Treating the inflammatory milieu may include removing or moderating pro-inflammatory stimuli, e.g., fluids, enhancing perfusion of the tissue at or near the internal tissue site, or providing reduced-pressure therapy. The reduced-pressure treatment device is placed at or near the internal tissue site and is fluidly coupled to an external reduced-pressure source. The reduced-pressure treatment device provides reduced pressure proximate the tissue site and treats the inflammatory milieu. The reduced-pressure treatment device for controlling inflammatory response may be a minimally-invasive treatment device. | 03-18-2010 |
20120101458 | REDUCED-PRESSURE SYSTEMS, DEVICES, AND METHODS FOR TREATING A TISSUE SITE THAT INCLUDES A FISTULA - Systems, methods, and devices are disclosed that involve a fistula-isolating device for use when reduced pressure is applied to a wound bed having a fistula. In one instance, the fistula-isolating device includes an adjustable passageway member and a perimeter member that contracts under reduced pressure and that automatically accommodates wound beds of different heights. In another instance, the fistula-isolating device involves a body shaped as a frustro-conical body that is readily sized for different depth wound beds. Other systems, methods, and devices are presented. | 04-26-2012 |
20120101512 | DEBRIDEMENT HAND TOOL - The disclosed embodiments include tools for aiding a user in debriding necrotic tissue. For example, in one embodiment, a debridement tool is disclosed that includes a housing having an interior space. A motor and a power source are disposed within the interior space of the housing. The power source is operable to provide power to the motor. A blade is coupled to a first end of the housing. The blade is operable to vibrate when the motor is powered. The debridement tool further includes a lighting element disposed within the housing and beneath a cutting edge of the blade. The lighting element is operable to illuminate the tissue site. In some embodiments, the lighting element operates at a particular wavelength that assists in distinguishing between necrotic tissue and healthy tissue. | 04-26-2012 |
20120238974 | REDUCED-PRESSURE SYSTEM AND METHOD EMPLOYING A GASKET - A reduced-pressure treatment system for treating a tissue site on a patient includes a gasket releasably attached around a perimeter of the tissue site that may remain in place for an extended time and allows an over-drape to be attached to it. The system and method further may include a manifold sized and configured to be placed in contact with the tissue site the over-drape positioned over the manifold and sealed to the gasket to create a sealed space between the over-drape and the tissue site; and a reduced-pressure source fluidly coupled to the sealed space to deliver reduced pressure to the tissue site. A method is also presented. | 09-20-2012 |
20120259274 | THERAPY DELIVERY SYSTEMS AND METHODS - Fluid removal systems and methods for removing fluid from a tissue site are presented. The system includes a semi-permeable inbound conduit, which is fluidly coupled to a treatment-fluid delivery unit, for placement proximate to the tissue site, and a semi-permeable outbound conduit, which is fluidly coupled to the inbound conduit and to a treatment-fluid collector, for placement proximate to the tissue site of a patient. The treatment-fluid collector receives a treatment fluid and a recruited fluid from the tissue site. A recruited-fluid determination unit may be coupled to the treatment-fluid collector to determine a volume of fluid recruited from the patient. The treatment fluid is any fluid (including a gas) that pulls fluid from the interstitial and intracellular space. A reduced-pressure treatment subsystem may also be included, among other things, for removing ascites and other fluids from a body cavity. | 10-11-2012 |
20120283674 | SYSTEMS AND METHODS FOR CONTROLLING INFLAMMATORY RESPONSE - A method and system for controlling inflammatory response at an internal tissue site of a patient utilizes a reduced-pressure treatment device. Controlling the inflammatory response may be accomplished in a number of ways that involve treating the inflammatory milieu. Treating the inflammatory milieu may include removing or moderating pro-inflammatory stimuli, e.g., fluids, enhancing perfusion of the tissue at or near the internal tissue site, or providing reduced-pressure therapy. The reduced-pressure treatment device is placed at or near the internal tissue site and is fluidly coupled to an external reduced-pressure source. The reduced-pressure treatment device provides reduced pressure proximate the tissue site and treats the inflammatory milieu. The reduced-pressure treatment device for controlling inflammatory response may be a minimally-invasive treatment device. | 11-08-2012 |
20140309601 | REDUCED-PRESSURE SYSTEMS, DEVICES, AND METHODS FOR TREATING A TISSUE SITE THAT INCLUDES A FISTULA - Systems, methods, and devices are disclosed that involve a fistula-isolating device for use when reduced pressure is applied to a wound bed having a fistula. In one instance, the fistula-isolating device includes an adjustable passageway member and a perimeter member that contracts under reduced pressure and that automatically accommodates wound beds of different heights. In another instance, the fistula-isolating device involves a body shaped as a frustro-conical body that is readily sized for different depth wound beds. Other systems, methods, and devices are presented. | 10-16-2014 |